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Abstract
CD148 is a new cluster of differentiation defined in the VI International Workshop on Leucocyte Differentiation Antigens. It
has been identified as the hematopoietic form of a formerly described membrane protein tyrosine phosphatase called HPTPh:
DEP-1. Previous data have demonstrated that this molecule is able to give rise to [Ca2]i increase. In the present work we show
its capability to induce protein tyrosine phosphorylation in human lymphocytes in spite of its intrinsic protein tyrosine
phosphatase activity. The induction of kinase activity suggests the involvement of some protein tyrosine kinase based signaling
pathway. The activation of this postulated kinase could be carried out through a direct association or via an adapter molecule.
© 1997 Elsevier Science B.V.
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1. Introduction
Tyrosine phosphorylation is an essential regulatory
mechanism used in signal transduction cascades to con-
trol cell proliferation, differentiation and migration
[1,2]. Regulation of tyrosine phosphorylation is carried
out by the concerted activities of protein tyrosine ki-
nases and protein tyrosine phosphatases. Leukocytes
express a wide variety of protein tyrosine phosphatases
which include cytosolic phosphatases, such as PTP-1C
and PTP-1D, or transmembrane phosphatases. An in-
creasing number of receptor function protein tyrosine
phosphatases have been identified [3], CD45 being the
most relevant one.
CD148 was defined during the VI International
Workshop on Lymphocyte Differentiation Antigens [4]
using two monoclonal antibodies: A3 and 143.41, the
last one produced and studied in our laboratory. The
CD148 molecule is present on different subpopulations
of peripheral blood cells with different levels of expres-
sion, showing its highest expression on granulocytes,
and being present at intermediate intensity on mono-
cytes and lymphocytes. After immunopurifying and
partial microsequencing the protein, CD148 was iden-
tified as the type III transmembrane protein tyrosine
phospahatase HPTPh:DEP-1 (de la Fuente et al. sub-
mitted for publication), previously cloned by two inde-
pendent groups [5,6]. This molecule was shown to have
an extracellular portion composed of eight or ten
fibronectin III domains, a transmembrane segment and
an intracytoplasmic tail which contains a single protein
tyrosine phosphatase domain, in contrast with most
receptor protein tyrosine phosphatases which contain a
tandem repeat of two cytoplasmic phosphatase do-
mains. The presence of fibronectin III motifs in the
extracellular domains suggests its possible involvement
in cell adhesion processes. On the other hand, the
existence of the phosphatase domain in the intracyto-
plasmic tail evidences its participation in signal trans-
duction.
Previous results in our laboratory have shown that
CD148 crosslinking was able to induce Ca2 mobiliza-
tion (de la Fuente et al. submitted for publication). This
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effect could be abolished by the addition of genistein,
a known protein tyrosine kinase inhibitor, as well as
by co-crosslinking with CD45, suggesting the involve-
ment of a tyrosine kinase based signaling. In the
present paper we have analyzed the ability of CD148
to induce tyrosine phosphorylation and compared it
with the effect of CD45, a protein tyrosine phos-
phatase also present on the membrane of lymphocytes.
2. Material and methods
2.1. Cells
Blood samples were obtained from healthy adult
donors. Peripheral blood mononuclear cells were iso-
lated by centrifugation over Ficoll-Hypaque (Pharma-
cia LKB, Uppsala, Sweden) density-gradient
sedimentation.
2.2. Monoclonal antibodies
The following mAbs were produced in our labora-
tory and ascribed to their CDs through one of the
International Workshops on Human Leukocyte Differ-
entiation Antigens: 143–41 (CD148, IgG1), CRIS-7
(CD3, IgG2a) and 72-5D3 (CD45, IgG2a).
2.3. Detection of tyrosine-phosphorylated proteins
Cells (5106) were incubated with the different
monoclonal antibodies (10 mg) for 15 min at 4°C
followed by the addition of cross-linking rabbit anti-
mouse immunoglobulins (5 mg). Incubation was termi-
nated after different periods of time by the addition of
1 ml of ice-cold stop buffer (50 mM Hepes, 150 mM
NaCl, 100 mM NaF, 10 mM EDTA, 10 mM
Na4P2O7, 2 mM Sodium Pervanadate, 2 mM PMSF,
10 mg:ml aprotinin, 10 mg:ml pepstatin, 1 mg:ml leu-
peptin, 100 mM PAO). Cells were pelleted and lysed
with stop buffer containing 1% NP-40. Proteins were
separated by SDS-PAGE and transferred to nitrocellu-
lose membranes. Phosphotyrosine-containing proteins
were probed with anti-phosphotyrosine monoclonal
antibody PY-20 from Santa Cruz Biotechnology
(Santa Cruz, CA) and horseradish peroxidase conju-
gated rabbit anti-mouse and visualized by fluorogra-
phy with enhanced chemiluminiscence (ECL) reagent
(Amersham, Buckinghamshire, UK).
3. Results and discussion
In order to confirm the capacity of CD148 to induce
protein phosphorylation an assay consisting in a phos-
photyrosine immunoblot of differently stimulated cell
lysates was developed. As can be observed in Fig. 1,
after CD3 crosslinking a neat pattern of protein ty-
rosine phosphorylation was detected, as has been pre-
viously described [7]. In a similar way, after CD148
crosslinking also a clear pattern of phosphorylation
could be observed. Likewise, an increase in tyrosine
phosphorylation was observed after crosslinking
CD45, a known membrane protein tyrosine phos-
phatase used as a control. In addition to the phospho-
rylation of some substrates in common with both CD3
and CD45, CD148 was able to induce tyrosine phos-
phorylation of some specific substrates (e.g. 52 Kd).
On the other hand, some substrates clearly hyperphos-
phorylated after CD3 (e.g. 56 Kd) and CD45 (e.g. 32
Kd) stimulation were not detected after CD148 stimu-
lation.
These results show that the CD148 molecule partici-
pates in some signal transduction pathway that in-
volves protein tyrosine phosphorylation even though it
has a phosphatase activity. This apparent contradic-
tion could be explained by the possible dephosphory-
lation of some substrates whose kinase activity would
be activated by this dephosphorylation. Actually, the
requirement of CD45 in antigen-induced receptor sig-
naling is based on its regulatory capacity on the Src-
family protein tyrosine kinases p56lck and p59fyn [8].
By dephosphorylating a negative regulatory tyrosine
Fig. 1. CD148 crosslinking induces tyrosine phosphorylation on
lymphocytes. Cells were left untreated (NS) or incubated with CD3,
CD148 or CD45 and after washing, goat anti-mouse was added. The
cells were incubated during the indicated times, the reaction was
stopped by the addition of stop buffer and cells were lysed with lysis
buffer. Total lysates were subjected SDS-PAGE, transferred to
nitrocellulose paper and tyrosine phosphorylated proteins were de-
tected by immunoblot with anti-phosphotyrosine antibody.
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phosphorylation site at their carboxyl termini, CD45
causes an increase in kinase activity. In fact, it has
been shown that p56lck co-immunoprecipitates with
CD45 thus establishing a link between these two
molecules [9]. Although we have no data on the ef-
fect of CD148 on p56lck, no clear phosphorylation of
substrates around 56 Kd was detected after CD148
stimulation. In any case, the observed increase in ty-
rosine phosphorylation suggests the implication of
some tyrosine kinase which could interact with
CD148 directly or through an adapter.
The 3BP2 protein is a possible candidate as an
adapter molecule. A potential binding site of the SH2
domain of the 3BP2 protein, a YEN(L:V) motif, has
been described by Kuramochi et al. [10] in the cyto-
plasmic tail of byp, the murine equivalent of human
CD148. The presence of this motif is also observed in
the cytoplasmic tail of human CD148. The 3BP2
protein contains a proline-rich domain and a plek-
strin-homology domain (PH). The PH domain has
been found on several intracellular proteins impli-
cated in signaling [11] and has been postulated to
mediate regulated protein–protein interactions during
signaling, in a similar manner to the SH2 domain. In
addition to CD148 and other type III human phos-
phatases like HPTP-b and GLEPP-1, the 3BP2 bind-
ing domain is found on some other proteins present
in the membrane of haematopoietic cells: CD19,
CD72, human high affinity epsilon receptor, human
EPO receptor and human G-CSFR [12]. A common
characteristic of all these molecules is their capability
to induce tyrosine phosphorylation. Whether the
3BP2 molecule is implicated on the signal transduc-
tion pathway through CD148 or there is a direct in-
teraction with some protein tyrosine kinase remains
to be elucidated.
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